Evidence map›Paper›PMID 30135508›Full record

ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2018

HPV E4 expression and DNA hypermethylation of CADM1, MAL, and miR124-2 genes in cervical cancer and precursor lesions.

Marjolein van Zummeren, Wieke W Kremer, Annemiek Leeman, Maaike C G Bleeker, David Jenkins, Miekel van de Sandt, John Doorbar, Daniëlle A M Heideman, Renske D M Steenbergen, Peter J F Snijders and 4 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 2 pooled it
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 2 syntheses or guidelines pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. FAM19A4/miR124-2 Methylation Testing and Human Papillomavirus (HPV) 16/18 Genotyping in HPV-Positive Women Under the Age of 30 Years.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  13. Article
  14. Methylation-mediated silencing ofFrontiers in oncology · 2023
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Marjolein van ZummerenDepartment of Pathology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.
Wieke W KremerDepartment of Pathology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.
Annemiek LeemanDDL Diagnostic Laboratory, Rijswijk, The Netherlands.
Maaike C G BleekerDepartment of Pathology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.
David JenkinsDDL Diagnostic Laboratory, Rijswijk, The Netherlands.
Miekel van de SandtDDL Diagnostic Laboratory, Rijswijk, The Netherlands.
John DoorbarDepartment of Pathology, University of Cambridge, Cambridge, United Kingdom.
Daniëlle A M HeidemanDepartment of Pathology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.
Renske D M SteenbergenDepartment of Pathology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.
Peter J F SnijdersDepartment of Pathology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.
Gemma G KenterDepartment of Gynecology, Center for Gynecologic Oncology Amsterdam, Amsterdam, The Netherlands.
Wim G V QuintDDL Diagnostic Laboratory, Rijswijk, The Netherlands.
Johannes BerkhofDepartment of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands.
Chris J L M MeijerDepartment of Pathology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands. cjlm.meijer@vumc.nl.
Amsterdam UMC Location VUmc · NLDDL Diagnostic Laboratory · NLCentrum voor Gynaecologische Oncologie Amsterdam · NLUniversity of Cambridge · GB

Funding

Medical Research Council MC_PC_13050
6 · The paper itself

Abstract

In this study, we evaluate the expression of human papillomavirus E4 protein (marker for the onset of a productive infection) and hypermethylation of host-cell CADM1, MAL, and miR124-2 genes (marker for an advanced, transforming infection) in cervical intraepithelial neoplasia (CIN) and cancer. A total of 115 cervical lesions were categorized by 3 pathologists into no dysplasia, CIN1, CIN2, CIN3, or cancer by classical histomorphological grading criteria, and by an immunoscore (cumulative value: 0-6) grading system based on Ki-67 (score: 0-3) and p16

Indexed as

AdultBiomarkers, TumorCell Adhesion Molecule-1Disease ProgressionDNA MethylationFemaleHumansMembrane GlycoproteinsMicroRNAsMiddle AgedOncogene Proteins, ViralPapillomavirus InfectionsReceptors, Interleukin-1Uterine Cervical DysplasiaUterine Cervical NeoplasmsBiomarkers, TumorCADM1 protein, humanCell Adhesion Molecule-1Membrane GlycoproteinsMicroRNAsMIRN124 microRNA, humanoncogene protein E4, human papilloma virus type 1Oncogene Proteins, ViralReceptors, Interleukin-1TIRAP protein, human

Identifiers

PMID30135508
OpenAlexW2888090087

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.